About Delphinus
Changing the Landscape of Dense Breast Imaging
Experienced Direction
With a vision for improving breast imaging for all women, our Board of Directors shares our passion in developing new technology that breaks the barriers in breast cancer detection. Their confidence in our team members, alignment with our objectives, and on-going support provide a strong foundation that propels our team forward in our quest to change the landscape of breast imaging.
Board of Directors
Paul McCreadie, Chairman
Managing Director, Arboretum Ventures
Mark J. Forchette, Director
Medical Device Industry Executive
Michael Gross, Director
Managing Director, Beringea, LLC
John Neis, Director
Managing Director, Venture Investors LLC
Hugo Braun, Director
Partner & Co-founder, North Coast Technology Investors
Michael Fulton, M.D., Director
Managing Director, Hopen Life Sciences Ventures
Ronald Ho, Director
Medical Device Industry Executive
Rachel Brem, M.D., Director
Director, Breast Imaging and Intervention,
The George Washington University